AI Signal Dashboard
Last updated: 04.13 07:33
Top Undervalued
+0.5¢
↑7.5k(Yes)
Arbitrage Opportunity
3¢
Arbitrage
3.65%
Annualized yield
Measles cases in U.S. in 2026? AI analysis: • +0.5¢ undervalued • 3.65% arbitrage APY • Live Prediction Market fair value & mispricing alerts.
Arbitrage Plan:
Simultaneously buy YES on ↑10k and NO on ↑12.5k
Plan Description:
The current Yes price for ↑10k is 9.95c, while the No price for ↑12.5k is 87.5c. Since reaching 12.5...
🔓 Unlock Full Arb Plan (Pro)
Undervalued Options Insights:
Current market pricing indicates that over 2,000 U.S. measles cases in 2026 is almost certain. After...
🔓 Unlock Mispricing Insights (Pro)
Real-time High Yield Opportunities
View MoreAll
Outcomes
Market
Price
AI Fair
Value
Value
Edge
↑7.5k
YesNo
15.5¢
84.5¢
16¢
84¢
+0.5¢
0¢
↑12.5k
YesNo
12.5¢
87.5¢
12¢
88¢
0¢
+0.5¢
Expand to view all 7 options
⚠️ Risk Warning: Live data may lag! Prices can shift instantly due to news or low liquidity. Before trading, use AI Chat for [Live Recalculate], [Check Liquidity], [Trollbox Radar], or review [Fair Value Logic] to verify.
Movers
Apr 10, 2026 - Apr 13, 2026, the price of the ↑3k option rebounded from 71.5c to 83c, while the ↑10k option fell from 15.5c to 10c. This indicates the market adjusted its extreme outbreak expectations, shifting probability weights heavily toward a moderate outbreak of 3,000 to 5,000 cases.
Apr 10, 2026 - Apr 11, 2026, the price of the ↑3k option surged from 71.5c to 84c. This was likely due to the market reassessing the case growth rate from the latest CDC reports, or signs of new cluster outbreaks in local areas during spring, leading to a rapid resurgence in outbreak concerns.
Apr 9, 2026 - Apr 10, 2026, the price of the ↑3k option dropped significantly from 87c to 71.5c. This occurred because the market, after digesting the latest CDC data, concluded that the peak of the spring outbreak had passed, leading to a major downward revision of pessimistic annual forecasts.
Apr 3, 2026 - Apr 9, 2026, prices for all options remained highly stable with maximum fluctuations under 5c, as the market continued to consolidate awaiting new data.
Mar 28, 2026 - Apr 3, 2026, price fluctuations for all options were minimal. The market entered a stable wait-and-see period after the end of Q1, awaiting guidance from new spring case data.
Mar 27, 2026 - Mar 30, 2026, price fluctuations for all options were under 6c, with ↑3k and ↑4k showing slight pullbacks. The overall market remained in a consolidation phase, awaiting further spring outbreak data.
Mar 24, 2026 - Mar 27, 2026, all options fluctuated within 5c. The market continued its consolidation phase as traders awaited more CDC data to confirm if the outbreak trend continues.
Mar 22, 2026 - Mar 23, 2026, the ↑5k option surged from 38.5c to 51.5c. Reason: The market reacted violently to new CDC data (125 weekly cases), fueling panic bets on linear growth and challenging the expectation of a seasonal summer decline.
Mar 20, 2026 - Mar 22, 2026, the market was in consolidation, with no option moving more than 2c as traders digested Q1 data and awaited signs of a seasonal inflection.
Mar 16, 2026 - Mar 19, 2026, the ↑4k option corrected from 72c to 64.5c, indicating a brief subsiding of early panic.